Leukemia · 2018 · 63 citations · 15 references
PharmacyOncologyPharmacotherapyCancer PharmacologyImmuno-oncology PharmacotherapyImmunotherapyCancer ImmunotherapyDosing Of Immuno-oncology AgentsHematologic Malignancy PharmacotherapyImmune-related Adverse EventsImmunotherapy SafetyMultiple MyelomaDaratumumab TherapyMultiple Myeloma TherapyMultiple Myeloma Treatment
15
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
Henk M. Lokhorst, Torben Plesner, Jacob P. Laubach et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text
Drug Allergy: An Updated Practice Parameter
Annals of Allergy Asthma & Immunology · 2010 · 955 citations
Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
Ajai Chari, Attaya Suvannasankha, Joseph W. Fay et al. · Blood · 2017 · 443 citations · Full text
Medicine, Oncology, Pharmacotherapy +12